Mazandaran University of Medical Sciences is a medical university in Sari, Mazandaran province, Iran. It is one of the top medical universities in Iran. MazUMS is a type I university of medical Sciences and has more 8,000 students in different programs.

During the past decade, Mazandaran University of medical sciences conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Mazandaran University of medical sciences" are "Magnetic Resonance Imaging" (1 trials), "Methylprednisolone" (1 trials), "Multiple Sclerosis" (1 trials) and "Multiple Sclerosis, Relapsing-Remitting" (1 trials). Many other conditions were trialed in "Mazandaran University of medical sciences" in a lesser frequency.

Most popular intervention types in "Mazandaran University of medical sciences" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Methylprednisolone succinate" (1 trials), "Normal saline" (1 trials), "Placebo" (1 trials) and "Vitamin D" (1 trials). Other intervention names were less common.

The vast majority of trials in "Mazandaran University of medical sciences" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Mazandaran University of medical sciences". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were undefined completed trials in Mazandaran University of medical sciences, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Mazandaran University of medical sciences, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".